EU Draft Adds PFAS Limit for Barrier Films

The European Commission has released a draft proposal to expand PFAS controls under REACH Annex XVII, with a specific migration limit for functional Barrier Films used as barrier layers. The exact event date was not specified in the input, but the draft publication date provided is June 2, 2026. The proposed change may affect Barrier Films exported from China to the European Union for food packaging, pharmaceutical packaging, and new energy battery separator applications because suppliers would be expected to provide third-party PFAS screening reports and technical statements on alternative materials.

What the Draft Proposal Confirms

According to the information provided, the European Commission published a draft on June 2, 2026, proposing to bring perfluoroalkyl substances, known as PFAS, more comprehensively under REACH Annex XVII control.

The draft includes a specific requirement for functional films used as barrier layers. For Barrier Films, the proposed migration limit is 0.025 mg/kg.

The new requirements are expected to take effect in the first quarter of 2027. The affected export categories identified in the input include Barrier Films used in food packaging, pharmaceutical packaging, and new energy battery separator products exported from China to the European Union.

The information provided also states that suppliers would need to provide third-party PFAS screening reports and technical declarations for alternative materials.

Where the Compliance Pressure May Appear Across the Chain

Exporters and direct trade operators

From an industry perspective, companies directly handling exports to the European Union may face earlier pressure because trade documentation, product compliance files, and customer declarations are usually reviewed before shipment or contract execution. The proposed PFAS migration limit may therefore affect quotation preparation, order acceptance, customs-related document coordination, and buyer communication.

These companies may need to pay closer attention to whether every relevant Barrier Film product can be matched with a third-party PFAS screening report and whether the stated material system is consistent with technical declarations provided to European Union customers.

Raw material sourcing teams

Analysis shows that raw material procurement may become a key control point because PFAS risks can originate from additives, coating systems, surface treatment materials, or other functional components used to achieve barrier performance. Even if the finished product is the compliance target, procurement teams may need to request clearer supplier declarations and test-related documents from upstream sources.

The main business impact may appear in supplier selection, incoming material review, purchasing specifications, and replacement material evaluation. Procurement teams should monitor whether alternative materials can support both compliance expectations and the functional requirements of Barrier Films.

Converting and manufacturing companies

For manufacturers and converters, the proposed requirement may affect formulation control, coating processes, laminated film structures, production records, and batch traceability. What deserves closer attention is that a migration limit is linked not only to the presence of PFAS but also to how the finished film performs under defined compliance assessment conditions.

Manufacturing companies may therefore need to align internal quality control with third-party testing needs, ensure that technical documentation reflects actual production conditions, and avoid inconsistencies between product specifications, test samples, and delivered goods.

Supply chain service providers

Supply chain service providers, including testing coordination, compliance consulting, logistics documentation support, and buyer-side quality coordination, may see increased demand for document verification and report management. Their role may become more important where multiple suppliers, product grades, or end-use categories are involved.

The impact may appear in report collection, document validity checks, shipment file preparation, and communication between Chinese suppliers and European Union buyers. Service providers may need to track whether customer procurement files begin to include PFAS screening reports and alternative material statements as routine requirements.

Compliance Actions Companies Should Review Now

Map Barrier Film products by end use

Companies should first identify which products are used as functional barrier layers and which are linked to food packaging, pharmaceutical packaging, or new energy battery separator applications. This mapping is important because the proposed requirement is specifically connected with Barrier Films and a 0.025 mg/kg migration limit.

Prepare third-party PFAS screening evidence

The draft information indicates that suppliers would be required to provide third-party PFAS screening reports. Companies should therefore review whether existing test reports cover the relevant product, material structure, and production batch, and whether report content is suitable for communication with European Union customers.

Align specifications with alternative material declarations

Because the provided summary refers to technical statements on alternative materials, companies may need to ensure that material substitutions are reflected in product specifications, technical data sheets, customer files, and internal quality records. It would be risky to provide a declaration that is not aligned with actual raw material sourcing or production practice.

Review lead times before the expected 2027 start

The new rules are expected to become effective in the first quarter of 2027. Without assuming any additional transition details, companies can still assess whether testing, supplier confirmation, material replacement, and customer approval cycles may affect delivery planning for European Union orders.

Industry Reading: A Shift from Product Claims to Evidence Files

Analysis shows that this draft should be understood as more than a chemical restriction issue. For Barrier Films, it may push exporters and manufacturers toward evidence-based compliance, where product claims need to be supported by third-party screening reports, material declarations, and traceable technical documentation.

From an industry perspective, buyers in the European Union may place greater weight on PFAS-related compliance records when reviewing suppliers for food packaging, pharmaceutical packaging, and new energy battery separator materials. This is an analytical judgment based on the stated reporting expectations, not a confirmed purchasing rule.

Observably, the proposed 0.025 mg/kg migration limit may also increase the importance of early specification alignment. If a product relies on functional coatings or specialized barrier structures, companies may need more time to confirm whether alternative materials can meet both compliance and performance expectations.

It is more appropriate to understand this development as a possible tightening of regulatory and procurement readiness. The confirmed information does not provide cost figures, market size estimates, or company-level cases, so any assessment of commercial impact should remain cautious.

Closing Assessment

The proposed revision to REACH Annex XVII signals a potential compliance milestone for Barrier Films containing or associated with PFAS risk. If the requirement takes effect as expected in the first quarter of 2027, suppliers exporting relevant products from China to the European Union may need stronger testing, documentation, and material substitution readiness.

The practical impact should not be overstated before final regulatory details are confirmed. However, companies involved in Barrier Films for food packaging, pharmaceutical packaging, and new energy battery separator applications should treat the draft as an early warning for compliance preparation and customer document alignment.

Information Basis and Follow-up Points

This article is based on the supplied news title, the stated event timing information, and the provided event summary. Specific official source links were not provided in the input and should be verified continuously.

For this type of regulatory development, relevant source categories may include official European Union regulatory publications, European Commission materials, REACH Annex XVII updates, notified draft documents, accredited testing guidance, and buyer compliance requirements. No specific source link is cited here because none was provided in the input.

Further monitoring should focus on final policy wording, implementation timing, certification and testing practices, interpretation of the migration limit, changes in tender or procurement documents, supplier qualification requirements, and feedback from affected industries.